Australia markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
188.38-0.21 (-0.11%)
At close: 04:00PM EDT
187.15 -1.24 (-0.66%)
After hours: 07:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.44B
Enterprise value 32.19B
Trailing P/E 23.76
Forward P/E 10.85
PEG ratio (5-yr expected) 6.24
Price/sales (ttm)2.84
Price/book (mrq)1.73
Enterprise value/revenue 3.33
Enterprise value/EBITDA 14.96

Trading information

Stock price history

Beta (5Y monthly) -0.06
52-week change 3-29.69%
S&P500 52-week change 332.96%
52-week high 3269.43
52-week low 3181.31
50-day moving average 3198.16
200-day moving average 3219.13

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 31.4M
Shares outstanding 5145.66M
Implied shares outstanding 6145.66M
Float 8145.12M
% held by insiders 10.17%
% held by institutions 192.70%
Shares short (30 Sept 2024) 42.85M
Short ratio (30 Sept 2024) 42.62
Short % of float (30 Sept 2024) 42.21%
Short % of shares outstanding (30 Sept 2024) 41.96%
Shares short (prior month 30 Aug 2024) 43.34M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 318 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 11.98%
Operating margin (ttm)32.50%

Management effectiveness

Return on assets (ttm)5.19%
Return on equity (ttm)7.63%

Income statement

Revenue (ttm)9.67B
Revenue per share (ttm)66.66
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)N/A
EBITDA 2.73B
Net income avi to common (ttm)1.16B
Diluted EPS (ttm)7.93
Quarterly earnings growth (yoy)-1.40%

Balance sheet

Total cash (mrq)1.91B
Total cash per share (mrq)13.1
Total debt (mrq)6.66B
Total debt/equity (mrq)41.91%
Current ratio (mrq)2.29
Book value per share (mrq)109.05

Cash flow statement

Operating cash flow (ttm)1.78B
Levered free cash flow (ttm)1.27B